Search Results 81-90 of 14186 for anti-TNF drugs

1. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

   Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes strong association between ...

2. TEN - Diagnosis and treatment - Mayo Clinic

   ... medications that affect the whole body (systemic drugs), such as cyclosporine (Neoral, Sandimmune), etanercept (Enbrel) and intravenous immunoglobulin (IVIG).

3. Tofacitinib (oral route) - Mayo Clinic

   Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ...

4. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   "When we examined the risk for preeclampsia in those on anti-TNF therapy ... "We theorize that exposure to anti-TNF agents is a marker of more severe ...

5. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

   Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has ...

6. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

   Drugs & Supplements A-Z ... adalimumab in the treatment of UC. Participation ... Note: Subject may be enrolled if he/she has been exposed to other advanced ...

7. Inflammatory bowel disease biobank research update - Mayo Clinic

   ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

8. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

9. Tolmetin (oral route) - Mayo Clinic

   Tolmetin is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of arthritis (osteoarthritis, rheumatoid ...

10. Vaccine efficacy and antibody response among patients with IBD and recipients of immunosuppressive agents - Mayo Clinic

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD. MAC-20531112. Medical Professionals; Vaccine efficacy and ...